Matches in Nanopublications for { ?s ?p "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP406145.RAp8oPPbfVIVhcwWBvZmqcAIAfU_1dE-G6q5XiQz1TkWY130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406145.RAp8oPPbfVIVhcwWBvZmqcAIAfU_1dE-G6q5XiQz1TkWY130_provenance.
- NP756164.RAbdSbKCBsbmi7lwocN6RoBYnLl3npPJ0yDEniQq5CP2k130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756164.RAbdSbKCBsbmi7lwocN6RoBYnLl3npPJ0yDEniQq5CP2k130_provenance.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_provenance.
- NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899768.RAVGSd52ScqtnLFgDFMZhU6M_g5LgBsA82huUu10WSvgw130_provenance.
- assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP767125.RAq_8m-N_tB9VainUioKuaIxkPGceoyKimcWprhXgUK3Q130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767125.RAq_8m-N_tB9VainUioKuaIxkPGceoyKimcWprhXgUK3Q130_provenance.
- NP767127.RAFbeidY6mTHpCX5srnoS8PWHSO21La4RVegr3IWxxWPs130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767127.RAFbeidY6mTHpCX5srnoS8PWHSO21La4RVegr3IWxxWPs130_provenance.
- NP899731.RA1ml1Z8lgA2bp1MLArxESkOf5w6V6zwF5qF-_OxH22Hg130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899731.RA1ml1Z8lgA2bp1MLArxESkOf5w6V6zwF5qF-_OxH22Hg130_provenance.